These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28342907)

  • 1. Active placebo control groups of pharmacological interventions were rarely used but merited serious consideration: a methodological overview.
    Jensen JS; Bielefeldt AØ; Hróbjartsson A
    J Clin Epidemiol; 2017 Jul; 87():35-46. PubMed ID: 28342907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unreported formal assessment of unblinding occurred in 4 of 10 randomized clinical trials, unreported loss of blinding in 1 of 10 trials.
    Bello S; Moustgaard H; Hróbjartsson A
    J Clin Epidemiol; 2017 Jan; 81():42-50. PubMed ID: 27555081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quality of placebos used in randomized, controlled trials of lumbar and pelvic joint thrust manipulation-a systematic review.
    Puhl AA; Reinhart CJ; Doan JB; Vernon H
    Spine J; 2017 Mar; 17(3):445-456. PubMed ID: 27888138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review found no consistent difference in effect between more and less intensive placebo interventions.
    Fässler M; Meissner K; Kleijnen J; Hróbjartsson A; Linde K
    J Clin Epidemiol; 2015 Apr; 68(4):442-51. PubMed ID: 25639981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and Implications of Alternative Placebo Treatments: A Systematic Review and Network Meta-analysis of Osteoarthritis Trials.
    Bannuru RR; McAlindon TE; Sullivan MC; Wong JB; Kent DM; Schmid CH
    Ann Intern Med; 2015 Sep; 163(5):365-72. PubMed ID: 26215539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer.
    Partridge AH; Sepucha K; O'Neill A; Miller KD; Motley C; Swaby RF; Schneider BP; Dang CT; Northfelt DW; Sledge GW
    JAMA Oncol; 2015 Jun; 1(3):369-74. PubMed ID: 26114161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo--efficacy and adverse effects in controlled clinical trials.
    Weihrauch TR; Gauler TC
    Arzneimittelforschung; 1999 May; 49(5):385-93. PubMed ID: 10367099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of unblinding was infrequently and incompletely reported in 300 randomized clinical trial publications.
    Bello S; Moustgaard H; Hróbjartsson A
    J Clin Epidemiol; 2014 Oct; 67(10):1059-69. PubMed ID: 24973822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and factors associated with use of placebo control groups in randomized controlled trials in psoriasis: a cross-sectional study.
    Katz KA; Karlawish JH; Chiang DS; Bognet RA; Propert KJ; Margolis DJ
    J Am Acad Dermatol; 2006 Nov; 55(5):814-22. PubMed ID: 17052487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound Formulas of Traditional Chinese Medicine for the Common Cold: Systematic Review of Randomized, Placebo-controlled Trials.
    Li G; Cai L; Jiang H; Dong S; Fan T; Liu W; Xie L; Mao B
    Altern Ther Health Med; 2015; 21(6):48-57. PubMed ID: 26567449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo effect studies are susceptible to response bias and to other types of biases.
    Hróbjartsson A; Kaptchuk TJ; Miller FG
    J Clin Epidemiol; 2011 Nov; 64(11):1223-9. PubMed ID: 21524568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inadequate description of placebo and sham controls in a systematic review of recent trials.
    Webster RK; Howick J; Hoffmann T; Macdonald H; Collins GS; Rees JL; Napadow V; Madigan C; Price A; Lamb SE; Bishop FL; Bokelmann K; Papanikitas A; Roberts N; Evers AWM
    Eur J Clin Invest; 2019 Nov; 49(11):e13169. PubMed ID: 31519047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The matching quality of experimental and control interventions in blinded pharmacological randomised clinical trials: a methodological systematic review.
    Bello S; Wei M; Hilden J; Hróbjartsson A
    BMC Med Res Methodol; 2016 Feb; 16():18. PubMed ID: 26873063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amitriptyline versus placebo for major depressive disorder.
    Leucht C; Huhn M; Leucht S
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD009138. PubMed ID: 23235671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondroitin for osteoarthritis.
    Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imperfect placebos are common in low back pain trials: a systematic review of the literature.
    Machado LA; Kamper SJ; Herbert RD; Maher CG; McAuley JH
    Eur Spine J; 2008 Jul; 17(7):889-904. PubMed ID: 18421484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of placebos without deception compared with no treatment: protocol for a systematic review and meta-analysis.
    Petkovic G; Charlesworth JE; Kelley J; Miller F; Roberts N; Howick J
    BMJ Open; 2015 Nov; 5(11):e009428. PubMed ID: 26610763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-research study revealed several challenges in obtaining placebos for investigator-initiated drug trials.
    Speich B; Logullo P; Deuster S; Marian IR; Moschandreas J; Taji Heravi A; Gloy V; Briel M; Hopewell S;
    J Clin Epidemiol; 2021 Mar; 131():70-78. PubMed ID: 33242608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why use placebos in clinical trials? A narrative review of the methodological literature.
    Vickers AJ; de Craen AJ
    J Clin Epidemiol; 2000 Feb; 53(2):157-61. PubMed ID: 10729687
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.